Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion

This publication has 39 references indexed in Scilit:

• Platelet Lysates Produced from Expired Platelet Concentrates Support Growth and Osteogenic Differentiation of Mesenchymal Stem Cells
  PLOS ONE, 2013
• Prion removal capacity of plasma protein manufacturing processes
  Transfusion, 2012
• Donor Age of Human Platelet Lysate Affects Proliferation and Differentiation of Mesenchymal Stem Cells
  PLOS ONE, 2012
• The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma
  Transfusion Medicine and Hemotherapy, 2011
• Expansion of adipose tissue mesenchymal stromal progenitors in serum‐free medium supplemented with virally inactivated allogeneic human platelet lysate
  Transfusion, 2010
• Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow
  Stem Cells, 2009
• An update on the assessment and management of the risk of transmission of variant Creutzfeldt‐Jakob disease by blood and plasma products
  British Journal of Haematology, 2008
• Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
  Transfusion, 2007
• Reducing the risk of infection from plasma products: specific preventative strategies
  Blood Reviews, 2000
• Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA
  Journal of Clinical Investigation, 1973